The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Dr. Lal PathLabs Ltd

Dr. Lal PathLabs Ltd

BSE 539524 · NSE LALPATHLAB · ISIN INE600L01024 · Group A · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

₹1,930.70

-0.41%

BSE close, 28 August 2026

Market cap

₹32,406.57 cr

16.8 cr shares · Mid cap

Free float

₹15,004.47 cr

as published

P/E · P/B

59.4× · 15.60×

EPS ₹32.50 · BV ₹123.76

FY25-26 rev / PAT

2,647.60 / 508.20

₹ cr, as filed

Filings, window

14

6 selected · 43%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹1,272.00 52-WK HIGH ₹1,989.35 ₹1,930.70 92% of range
Against 52-week high-2.9%
Against 52-week low+51.8%
Day change-0.41%
Size bandMid cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹32.50
Price / earnings59.41×
Price / book15.60×
Book value — derived, price ÷ P/B₹123.76
Return on equity26.26%
Operating margin35.11%
Net margin21.70%

Consistency check

P/B ÷ P/E, which must equal ROE
26.26%
ROE as published
26.26%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 764.40 165.90 9.94 35.11% 21.70%
Mar-26 · Q 675.20 141.10 8.45 32.36% 20.90%
FY25-26 2,647.60 508.20 30.45 31.59% 19.19%

Quarter on quarter

Revenue, quarter on quarter
+13.2%
Net profit, quarter on quarter
+17.6%
Operating margin, quarter on quarter
+275 bps

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 24 sector max 59 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Acquisition5
Concall Transcript1
Selected sub-total6
Procedural
General2
Board Meeting1
Compliance Certificate1
ESOP Allotment1
Newspaper Publication1
Outcome1
Trading Window1
Procedural sub-total8
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

14 filings · 6 selected · busiest 2026-09-24 and 2026-09-25

Filing rhythm · the twelve most recent

2026-08-192026-10-13

SelectedProcedural

Filings

14 in the window · 24 earlier on record

  1. 13 October 2026 ·

    Acquisition

    Acquisition

    Attached

    Company Update / Acquisition View filing →

  2. 12 October 2026 ·

    Acquisition

    Acquisition

    Attached

    Company Update / Acquisition View filing →

  3. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Attached

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  4. 8 October 2026 ·

    General

    Intimation Under Regulation 30

    Attached

    Company Update / General View filing →

  5. 1 October 2026 ·

    Acquisition

    Updates on Acquisition

    Attached

    Company Update / Acquisition View filing →

  6. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Attached

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 25 September 2026 ·

    Board Meeting

    Board Meeting Intimation for The Quarter And Half Year Ending On September 30, 2026

    Dr. Lal Pathlabs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the un-audited (Standalone ....

    Board Meeting / Board Meeting View filing →

  8. 24 September 2026 ·

    Acquisition

    Acquisition

    Attached

    Company Update / Acquisition View filing →

  9. 24 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated September 24, 2026

    Attached

    Others / Outcome without intimation View filing →

  10. 4 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Attached

    Company Update / Newspaper Publication View filing →

  11. 27 August 2026 ·

    Acquisition

    Updates on Acquisition

    Attached

    Company Update / Acquisition View filing →

  12. 19 August 2026 ·

    General

    Inc orporation Of A Step-Down Subsidiary Company

    Attached

    Company Update / General View filing →

  13. 6 August 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Attached

    Company Update / Allotment of ESOP / ESPS View filing →

  14. 30 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Attached

    Company Update / Earnings Call Transcript View filing →

RSS feed for Dr. Lal PathLabs Ltd · the 50 most recent filings